A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respirator solution

Chest

Volumn 111, Issue 1, 1997, Pages 204-208

  MacNeish, Clair F ^a   Meisner, Dale ^b   Thibert, Roch ^b   Kelemen, Susan ^b   Vadas, Elizabeth B ^b   Coates, Allan L ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

aerosol; albuterol; bronchodilator; nebulization

Indexed keywords

SALBUTAMOL;

ARTICLE; DRUG BIOAVAILABILITY; INTERMETHOD COMPARISON; NEBULIZATION; NEBULIZER; PRIORITY JOURNAL; VENTILATOR;

EID: 0031020882     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.1.204     Document Type: Article

References (19)

1. Beasley CRW, Rafferty P, Holgate ST. Bronchoconstrictor properties of preservatives in ipratropriuni bromide (Atrovent) nebuliser solution. BMJ 1987; 294:1197-98
2. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract state of the art. Am Rev Respir Dis 1979; 120:1325-73
3. Gerrity TM, Lee PS, Hass FJ, et al. Calculated deposition of inhaled particles in the airway generation of normal subjects. J Appl Physiol 1979; 47:867-73
4. Newth CJL, Clark AR. In vitro performance of the small particle aerosol generator (SPRAG-2). Pediatr Pulmonol 1989; 7:183-88
5. Newman SP, Pellow PGD, Clay MM, et al. Evaluation of jet nebuliscrs for use with gentamicin solution. Thorax 1985; 40:671-76
6. Newman SP, Clarke SW. Therapentic aerosols: I. Physical and practical considerations, Thorax 1983; 38:881-86
7. Langford SA, Allen MB. Salbutamol output from two jet nebulizers. Respir Med 1993; 87:99-103
8. Ramsey BW, Astley SJ, Aitken ML, et al. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribomiclease in patients with cystic fibrosis. Am Rev Respir Dis 1993; 148:145-51
9. Mukhopadhyay S, Staddon GE, Eastman C, et al. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir Med 1994; 88:203-11
10. O'Callaghan C, Clarke AR, Milner AD. Inaecourate (sic) calculation of drug output from ncbulisers. Eur J Pediatr 1989; 148:473-74
11. Dennis JH, Stenton SC, Beach JR, et al. Jet and ultrasonic nebuliser output: use of a new method for direct measure-ment of aerosol output. Thorax 1990; 45:728-32
12. Wood JA, Wilson RSE, Bray C. Changes in salbutamol concentration in the reservoir solution of a jet nebulizer. Br J Dis Chest 1986; 80:164-69
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10
14. Clark AR, The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 1995; 115:69-78
15. Knoch M, Wunderlieh E, Geldner S. A nebulizer system for highly reproducible aerosol delivery. J Aerosol Med 1994; 3:229-37
16. Clay MM, Pavia D, Newman SP, et al. Assessment of jet nebulizers for lung aerosol therapy. Lancet 1983; 2:592-94
17. Adamson AW. Wilhelmy slide method. In: Adamson AW, ed. Physical chemistry of surfaces. 4th ed. New York: John Wiley. 1982; 24-6
18. Clay MM, Pavia D, Newman SP, et al. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983; 38:755-59
19. Collis GG, Cole CH, LeSouëf PN. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990; 336: 341-43